Employing functionalized fragment libraries to identify therapeutic agents for neurofibromatosis type 2
利用功能化片段库来鉴定 2 型神经纤维瘤病的治疗药物
基本信息
- 批准号:10704416
- 负责人:
- 金额:$ 41.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-01-01 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Neurofibromatosis type 2 (NF2) is a dominantly inherited autosomal disease with the most common
manifestation being development of bilateral schwannomas of the 8th cranial nerve (Vestibular schwannoma).
The majority of NF2 patients develop additional tumors throughout the nervous system, including schwannomas,
meningiomas and ependymomas, causing severe morbidity and early mortality. The NF2 tumor suppressor gene
encodes for a 69-kDa protein called Merlin, implicated in the regulation of a number of signaling pathways, such
as those regulated by small G-proteins and the Hippo-YAP signaling pathway. Although our understanding of
the molecular mechanisms underlying NF2 has improved over the past two decades, effective therapies remain
lacking.
To date, systematic efforts to identify therapeutic agents for NF2 have demonstrated limited success, resulting
in identification of a small number of candidates that displayed minimal selectivity towards NF2-deficient cells.
Arguably, the reasons for this limited success stem from a number of factors including the fact these efforts relied
on approaches utilizing traditional screening assays performed with cells plated on plastic dishes, in 2-
dimensional (2D) monolayer formats. These conditions poorly reflect the environment cells experience in vivo.
In addition, previous screens were performed against a small collection of compounds that were pre-selected
based on drug-likeness, known pharmacology, regulatory status, etc. Thus, only limited chemical space has
been explored in these efforts.
Our long-term goals are to identify small molecules that selectively inhibit NF2-null Schwann cells and optimize
these into lead molecules that will be developed into therapeutic agents. Towards this goal we will implement a
screening campaign that incorporates a number of innovations that we already demonstrated to dramatically
improve discovery efforts. We hypothesize that the proposed research campaign will identify pharmacologically
tractable targets/pathways in NF2-null cells, which will be developed as leads for therapeutic development.
2型神经纤维瘤病(NF2)是一种显性遗传常染色体疾病
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOSEPH KISSIL其他文献
JOSEPH KISSIL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOSEPH KISSIL', 18)}}的其他基金
Elucidating the epigenetic landscape of neurofibromatosis and development of therapeutic targets
阐明神经纤维瘤病的表观遗传景观和治疗靶点的开发
- 批准号:
10473771 - 财政年份:2021
- 资助金额:
$ 41.57万 - 项目类别:
Employing functionalized fragment libraries to identify therapeutic agents for neurofibromatosis type 2
利用功能化片段库来鉴定 2 型神经纤维瘤病的治疗药物
- 批准号:
10401628 - 财政年份:2021
- 资助金额:
$ 41.57万 - 项目类别:
Elucidating the epigenetic landscape of neurofibromatosis and development of therapeutic targets
阐明神经纤维瘤病的表观遗传景观和治疗靶点的开发
- 批准号:
10680527 - 财政年份:2021
- 资助金额:
$ 41.57万 - 项目类别:
Elucidating the epigenetic landscape of neurofibromatosis and development of therapeutic targets
阐明神经纤维瘤病的表观遗传景观和治疗靶点的开发
- 批准号:
10211400 - 财政年份:2021
- 资助金额:
$ 41.57万 - 项目类别:
CARM1-mediated regulation of YAP1 as a therapeutic target in lung cancer
CARM1 介导的 YAP1 调节作为肺癌的治疗靶点
- 批准号:
10391561 - 财政年份:2020
- 资助金额:
$ 41.57万 - 项目类别:
CARM1-mediated regulation of YAP1 as a therapeutic target in lung cancer
CARM1 介导的 YAP1 调节作为肺癌的治疗靶点
- 批准号:
10613467 - 财政年份:2020
- 资助金额:
$ 41.57万 - 项目类别:
Elucidating the epigenetic landscape of neurofibromatosis and development of therapeutic targets
阐明神经纤维瘤病的表观遗传景观和治疗靶点的开发
- 批准号:
10201375 - 财政年份:2020
- 资助金额:
$ 41.57万 - 项目类别:
相似海外基金
Continuous, Large-scale Manufacturing of Functionalized Silver Nanowire Transparent Conducting Films
功能化银纳米线透明导电薄膜的连续大规模制造
- 批准号:
2422696 - 财政年份:2024
- 资助金额:
$ 41.57万 - 项目类别:
Standard Grant
A methodology to connect functionalized gonadal constructs to a chick embryo through mechanically induced blood vessels from an egg
一种通过鸡蛋机械诱导血管将功能化性腺结构连接到鸡胚胎的方法
- 批准号:
24K15741 - 财政年份:2024
- 资助金额:
$ 41.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
NPBactID - Differential binding of peptoid functionalized nanoparticles to bacteria for identifying specific strains
NPBactID - 类肽功能化纳米粒子与细菌的差异结合,用于识别特定菌株
- 批准号:
EP/Y029542/1 - 财政年份:2024
- 资助金额:
$ 41.57万 - 项目类别:
Fellowship
EAGER: CET: Functionalized Graphene for Sustainable Rare Earth Metal Separation
EAGER:CET:用于可持续稀土金属分离的功能化石墨烯
- 批准号:
2337221 - 财政年份:2023
- 资助金额:
$ 41.57万 - 项目类别:
Standard Grant
Dual Catalysis of Superatomic Metal Nanocluster Functionalized by Supramolecular Reaction Field
超分子反应场功能化超原子金属纳米团簇的双重催化
- 批准号:
23KJ1383 - 财政年份:2023
- 资助金额:
$ 41.57万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Towards Ultrasensitive Detection of Bacterial Extracellular Electron Transfer in Human Gut by Novel Functionalized Carbon Nanotube Electrode Interfaces and Organic Microbial Electrochemical Transistor
通过新型功能化碳纳米管电极接口和有机微生物电化学晶体管对人体肠道中细菌细胞外电子转移进行超灵敏检测
- 批准号:
23K13651 - 财政年份:2023
- 资助金额:
$ 41.57万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unprecedented and potent immunoregulation provided by protein capture with functionalized small synthetic nucleic acids
通过功能化小合成核酸捕获蛋白质提供前所未有的有效免疫调节
- 批准号:
23H00317 - 财政年份:2023
- 资助金额:
$ 41.57万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
A general way to selective-functionalized pillar[n]arenes and their supramolecular mate rials
选择性功能化柱芳烃及其超分子材料的通用方法
- 批准号:
23KF0235 - 财政年份:2023
- 资助金额:
$ 41.57万 - 项目类别:
Grant-in-Aid for JSPS Fellows
EFRI ELiS: Biofilm-functionalized and -maintained, living infrastructure systems
EFRI ELiS:生物膜功能化和维护的生活基础设施系统
- 批准号:
2223756 - 财政年份:2023
- 资助金额:
$ 41.57万 - 项目类别:
Continuing Grant
Boron-Functionalized pi-Conjugated Materials with Tailored Properties
具有定制特性的硼功能化π共轭材料
- 批准号:
2247211 - 财政年份:2023
- 资助金额:
$ 41.57万 - 项目类别:
Standard Grant